Clinical trial
A Three-Part Study Of GSK580416 In Healthy Subjects
NCT00427141 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00427141 |
|---|---|
| Title | A Three-Part Study Of GSK580416 In Healthy Subjects |
| Official title | A Three-part First Time in Human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Food Effect of Single Oral Doses of GSK580416 in Healthy Adult Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Respiratory Tract Infection, Infections, Bacterial |
| Intervention type | Drug |
| Interventions | GSK580416 |
| Enrollment | 48 |
| Start date | Oct 1, 2006 |
| First posted | Jan 26, 2007 |
| Last update posted | Jun 4, 2012 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: